Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Booster 10-valent pneumococcal conjugate vaccine with co-administered MMRV in toddlers previously primed in infancy
2006-001934-42Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2006
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of 10-valent pneumococcal conjugate vaccine and GSK208136 in pneumococcal disease, measles, mumps and 2 more (2 arms), sponsored by GSK. Primary endpoint: Incidence of post-immunization rectal fever greater than 39.0°C. Started Jun 2006; status: completed.
02
Drugs
10-valent pneumococcal conjugate vaccineGSK208136
03
Conditions
pneumococcal diseasemeaslesmumpsrubellachickenpox
Beyond the preview
Go deeper on 2006-001934-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001934-42.